Amanote Research
Register
Sign In
Discovery of SCY45, a Natural Small‐Molecule MDM2‐p53 Interaction Inhibitor.
Chemistry and Biodiversity
- United States
doi 10.1002/cbdv.201900269
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Biochemistry
Medicine
Bioengineering
Chemistry
Date
May 23, 2019
Authors
Unknown
Publisher
Wiley
Related search
P53 Mediated Death of Cells Overexpressing MDM2 by an Inhibitor of MDM2 Interaction With P53
Oncogene
Cancer Research
Genetics
Molecular Biology
Pharmacologic Activation of P53 by Small-Molecule MDM2 Antagonists
Current Pharmaceutical Design
Drug Discovery
Pharmacology
Systems-Based Discovery of Tomatidine as a Natural Small Molecule Inhibitor of Skeletal Muscle Atrophy
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Discovery of Potent and Simplified Piperidinone-Based Inhibitors of the MDM2–p53 Interaction
ACS Medicinal Chemistry Letters
Organic Chemistry
Biochemistry
Drug Discovery
The Isolation, Total Synthesis and Structure Elucidation of Chlorofusin, a Natural Product Inhibitor of the P53–MDM2 Protein–protein Interaction
Natural Product Reports
Biochemistry
Organic Chemistry
Drug Discovery
Targeting Neuroblastoma With a New Inhibitor of the TAp73 Interaction With MDM2 and Mutant P53
Discovery of MINC1, a GTPase-Activating Protein Small Molecule Inhibitor, Targeting MgcRacGAP
Combinatorial Chemistry and High Throughput Screening
Medicine
Organic Chemistry
Drug Discovery
Computer Science Applications
Development of Noncytotoxic PLGA Nanoparticles to Improve the Effect of a New Inhibitor of P53–MDM2 Interaction
International Journal of Pharmaceutics
Pharmaceutical Science
The Interaction Between P53 and Mdm2 Is Independent of MEG3–p53 Association
